Immune-related adverse events of tirelizumab in 424 cases of cancer patients
ZHANG Jian, ZHANG Lingli, LI Xin
Chinese Journal of Pharmacovigilance . 2024, (4): 435 -439 .  DOI: 10.19803/j.1672-8629.20240091